The evolving perspective of prostate cancer: a question of natural history and current treatment trends
Fischinger, P.J.
Journal of the South Carolina Medical Association 90(5): 242-248
1994
ISSN/ISBN: 0038-3139 PMID: 8028297 Document Number: 430011
Document emailed within 1 workday
Related Documents
Peneau, M.; Piéchaud, T.; Cariou, G.; Ragni, E.; Fontaine, E.; Fournier, G. 1998: Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(6): 977-993Yossepowitch, O. 2007: This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HT European Urology 52(2): 453
Okihara, K. 2016: Current status and future perspective in Japanese prostate cancer screening Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl. 3: 275-279
2015: (S012) Trends in the Selection of Definitive Treatment for Newly Diagnosed Prostate Cancer in Men < 60 Years Old Oncology 29(4 Suppl. 1)
Koiso, K. 1985: Current trends in the treatment of bladder cancer Nursing Technique 31(11): 1413-1417
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107
Kaprin, A.D.; Khmelevskiĭ, E.V.; Fadeev, A.V. 2008: Current methods of radical treatment for localized prostate cancer Voprosy Onkologii 54(1): 108-112
Guan, X-xiang.; Chen, L-bang. 2006: Current opinions on the treatment of androgen-independent prostate cancer Zhonghua Nan Ke Xue 12(11): 1021-1025
Petrylak, D.P. 2011: Evolving therapeutic paradigms for advanced prostate cancer: what's needed to make optimal use of the new treatments Oncology 25(6): 514-515
1983: Presentation of the question introduced for discussion: history of the maxilla. Can current orthodontic therapies mitigate maxillary growth deficiencies? L' Orthodontie Francaise 54(2): 527-560
Ahluwalia, G.; Sharma, S.K. 2004: Dengue: current trends and challenges--an Indian perspective Journal of the Association of Physicians of India 52: 561-563
Bostwick, D.G. 1994: Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer American Journal of Clinical Pathology 102(4 Suppl 1): S31-S37
Feldman-Stewart, D.; Brundage, M.D.; Van Manen, L.; Skarsgard, D.; Siemens, R. 2003: Evaluation of a question-and-answer booklet on early-stage prostate-cancer Patient Education and Counseling 49(2): 115-124
Kitagawa, D.; Toi, M. 2007: Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 6: 396-401
White, R.A.; Cavaye, D.M. 1993: Endovascular surgery: history, current status and future perspective International Angiology: a Journal of the International Union of Angiology 12(3): 197-205
Hornsby-Lewis, L.; Winawer, S.J. 1990: Natural history and current management of colorectal polyps Oncology 4(4): 139-144; Discussion 144: 147-148
Lessick, M.; Katz, A. 2006: A genetics perspective on prostate cancer Urologic Nursing 26(6): 454-460
Little, M.A.; Pusey, C.D. 2004: Rapidly progressive glomerulonephritis: current and evolving treatment strategies Journal of Nephrology 17(Suppl): S10-S19
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Ward-Smith, P. 2003: Brachytherapy for prostate cancer: the patient's perspective Urologic Nursing 23(3): 213-217